Ambrx Biopharma, Inc.

Biological Products, (No Diagnostic Substances)·LA JOLLA, CA

Financials

1 shown

Type	Period	Ended	Filed
10-Q	Q3 2023	9/30/23	11/13/23	→

News (8-K)

8 shown

Filed	Type	Description
3/12/24	Exec Change	Departure or Appointment of Directors or Certain Officers	→
3/7/24	Delisting	Termination of a Material Definitive Agreement	→
3/6/24	Reg FD	Submission of Matters to a Vote of Security Holders	→
2/22/24	Other	Other Events	→
1/8/24	Agreement	Entry into a Material Definitive Agreement	→
12/1/23	Exec Change	Departure or Appointment of Directors or Certain Officers	→
↓

Prospectuses & Registrations

14 shown

Filed	Form	Description
3/8/24	S-8 POS	S-8 POS	→
3/8/24	S-8 POS	S-8 POS	→
3/8/24	S-8 POS	S-8 POS	→
3/8/24	S-8 POS	S-8 POS	→
3/8/24	S-8 POS	S-8 POS	→
10/17/23	S-3	S-3	→
↓

Filing History(77 filings)

TypeDateAccessionPeriodSize

SC 13G/A

Nov 14, 2024

0001172661-24-004740

—

100.7 KB

15-12G

Mar 18, 2024

0000950157-24-000430

—

11.0 KB

8-K

Mar 12, 2024

0000950157-24-000386CURRENT REPORT

Mar 8, 2024

159.2 KB

EFFECT

Mar 8, 2024

9999999995-24-000625

—

1.8 KB

S-8 POS

Mar 8, 2024

0001193125-24-063394S-8 POS

—

27.3 KB

S-8 POS

Mar 8, 2024

0001193125-24-063386S-8 POS

—

27.3 KB

S-8 POS

Mar 8, 2024

0001193125-24-063378S-8 POS

—

27.3 KB

S-8 POS

Mar 8, 2024

0001193125-24-063372S-8 POS

—

27.3 KB

S-8 POS

Mar 8, 2024

0001193125-24-063370S-8 POS

—

27.3 KB

Mar 7, 2024

0000950170-24-0282504

Mar 7, 2024

13.6 KB

Mar 7, 2024

0000950170-24-0282424

Mar 7, 2024

11.6 KB

Mar 7, 2024

0000950170-24-0281904

Mar 7, 2024

16.1 KB

Mar 7, 2024

0000950170-24-0281884

Mar 7, 2024

13.7 KB

Mar 7, 2024

0000950170-24-0281864

Mar 7, 2024

12.0 KB

Mar 7, 2024

0000950170-24-0281824

Mar 7, 2024

20.3 KB

Mar 7, 2024

0000950170-24-0281774

Mar 7, 2024

8.7 KB

Mar 7, 2024

0000950170-24-0281714

Mar 7, 2024

11.5 KB

POS AM

Mar 7, 2024

0001193125-24-061871POS AM

—

21.0 KB

25-NSE/A

Mar 7, 2024

0001354457-24-000131

—

3.0 KB

8-K

Mar 7, 2024

0001193125-24-0615438-K

Mar 7, 2024

327.8 KB

8-K

Mar 6, 2024

0001193125-24-0607128-K

Mar 6, 2024

171.0 KB

DEFA14A

Feb 23, 2024

0001193125-24-044329DEFA14A

—

113.3 KB

DEFA14A

Feb 22, 2024

0001193125-24-042135DEFA14A

—

33.2 KB

8-K

Feb 22, 2024

0001193125-24-0421318-K

Feb 21, 2024

153.2 KB

DFAN14A

Feb 15, 2024

0001193125-24-037665DFAN14A

—

626.6 KB

25 filings shown

Ambrx Biopharma, Inc.

Financials

News (8-K)

Prospectuses & Registrations

Filing History(77 filings)

Proxies

Ownership

Other Filings

Filed	Form	Description
2/23/24	DEFA14A	DEFA14A	→
2/22/24	DEFA14A	DEFA14A	→
1/29/24	DEFM14A	DEFM14A	→
1/19/24	PREM14A	PREM14A	→
1/8/24	DEFA14A	DEFA14A	→

Filed	Form	Description
11/14/24	SC 13G/A	SC 13G/A	→
3/7/24	4	4	→
3/7/24	4	4	→
3/7/24	4	4	→
3/7/24	4	4	→
3/7/24	4	4	→
↓

Filed	Form	Description
3/18/24	15-12G	15-12G	→
3/8/24	EFFECT	EFFECT	→
3/7/24	POS AM	POS AM	→
3/7/24	25-NSE/A	25-NSE/A	→
2/15/24	DFAN14A	DFAN14A	→
1/29/24	DFAN14A	DFAN14A	→
↓